Through RNA-binding protein immunoprecipitation (RIP)-sequencing, we find that NONO promotes HCC progression by interacting with and increasing ACLY mRNA to enhance FA biosynthesis. The gene discussed is ACLY; the disease is hepatocellular carcinoma.